Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$1.48 - $2.35 $1.29 Million - $2.05 Million
-872,000 Reduced 43.46%
1,134,511 $2.54 Million
Q4 2019

Feb 05, 2020

BUY
$1.77 - $3.84 $3.55 Million - $7.71 Million
2,006,511 New
2,006,511 $7.71 Million

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.